异丙酚
体内
膀胱癌
流式细胞术
PI3K/AKT/mTOR通路
药理学
化学
蛋白激酶B
活力测定
癌症
免疫系统
细胞
癌症研究
癌细胞
细胞生长
免疫印迹
医学
免疫学
生物
细胞凋亡
内科学
生物化学
生物技术
基因
作者
Jin Jun Luo,Kun He,Shuqing Zhen,Y Wang,Huifang Guo,Hongxia Shen,Fei-yun Ping
摘要
Bladder cancer is a highly prevalent malignancy. Asiaticoside (AC), a triterpenoid derivative, exhibits antitumor effect on different tumors. This study aimed to explore the role and mechanism of AC on bladder cancer. J82 and T24 cells were treated with AC and/or propofol, and nude mice were subcutaneously administrated with T24 cells. The effect and mechanism of AC and/or propofol were explored by cell counting kit-8, transwell, flow cytometry, enzyme-linked immunosorbent assay, immunohistochemistry and western blot assays both in vitro and in vivo. Cell viability of J82 and T24 cells was inhibited by AC with a IC50 value of 2.43 μM and 2.16 μM, and by propofol with a IC50 value of 42.51 μM and 48.37 μM, respectively. AC or propofol alone decreased cell proliferation, invasion, and immune escape with the increased ferroptosis, as well as downregulating the level of the PI3K/AKT pathway in both animal and cell experiments. The effect of propofol on the above-mentioned indicators was further enhanced with the co-treatment of AC in vitro and in vivo. Taken together, AC promoted the ameliorative effect of propofol on bladder cancer involved in PI3K/AKT pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI